Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects

S Barua, S Mitragotri - Nano today, 2014 - Elsevier
Nanoparticles (NPs) have emerged as an effective modality for the treatment of various
diseases including cancer, cardiovascular and inflammatory diseases. Various forms of NPs …

Microneedle technologies for (trans) dermal drug and vaccine delivery

K Van Der Maaden, W Jiskoot, J Bouwstra - Journal of controlled release, 2012 - Elsevier
Microneedles have been used for the dermal and transdermal delivery of a broad range of
drugs, such as small molecular weight drugs, oligonucleotides, DNA, peptides, proteins and …

Intradermal and transdermal drug delivery using microneedles–Fabrication, performance evaluation and application to lymphatic delivery

AH Sabri, Y Kim, M Marlow, DJ Scurr, J Segal… - Advanced drug delivery …, 2020 - Elsevier
The progress in microneedle research is evidenced by the transition from simple 'poke and
patch'solid microneedles fabricated from silicon and stainless steel to the development of …

Microneedles: an emerging transdermal drug delivery system

SH Bariya, MC Gohel, TA Mehta… - Journal of Pharmacy …, 2012 - academic.oup.com
Objectives One of the thrust areas in drug delivery research is transdermal drug delivery
systems (TDDS) due to their characteristic advantages over oral and parenteral drug …

The growing role of nanotechnology in combating infectious disease

K Blecher, A Nasir, A Friedman - Virulence, 2011 - Taylor & Francis
The treatment and prevention of infectious diseases is a major part of both clinical and
investigative medicine. As the use of conventional antibiotics rises, antimicrobial resistance …

Particulate vaccines: on the quest for optimal delivery and immune response

ML De Temmerman, J Rejman, J Demeester… - Drug discovery today, 2011 - Elsevier
Subunit vaccines offer a safer alternative to traditional organism-based vaccines, but their
immunogenicity is impaired. This hurdle might be overcome by the use of micro-and …

Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release

W Jiskoot, TW Randolph, DB Volkin… - Journal of …, 2012 - Elsevier
Protein instability and immunogenicity are two main roadblocks to the clinical success of
novel protein drug delivery systems. In this commentary, we discuss the need for more …

N, N, N-Trimethyl chitosan: An advanced polymer with myriad of opportunities in nanomedicine

AD Kulkarni, HM Patel, SJ Surana, YH Vanjari… - Carbohydrate …, 2017 - Elsevier
Abstract N, N, N-trimethyl chitosan (TMC), a quaternized hydrophilic derivative of chitosan
(CHT), outperformed the well-known solubility issues raised by CHT. The excellent …

Advances in transcutaneous vaccine delivery: do all ways lead to Rome?

SM Bal, Z Ding, E van Riet, W Jiskoot… - Journal of controlled …, 2010 - Elsevier
Transcutaneous immunization (TCI) is a promising alternative to vaccine delivery via the
subcutaneous and intramuscular routes, due to the unique immunological characteristics of …

Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in …

B Slütter, S Bal, C Keijzer, R Mallants, N Hagenaars… - Vaccine, 2010 - Elsevier
Nasal vaccination is a promising, needle-free alternative to classical vaccination.
Nanoparticulate delivery systems have been reported to overcome the poor immunogenicity …